NO20006479L - Tienopyridinforbindelser, deres fremstilling og anvendelse - Google Patents

Tienopyridinforbindelser, deres fremstilling og anvendelse

Info

Publication number
NO20006479L
NO20006479L NO20006479A NO20006479A NO20006479L NO 20006479 L NO20006479 L NO 20006479L NO 20006479 A NO20006479 A NO 20006479A NO 20006479 A NO20006479 A NO 20006479A NO 20006479 L NO20006479 L NO 20006479L
Authority
NO
Norway
Prior art keywords
tienopyridine
compounds
preparation
cancer
sex hormone
Prior art date
Application number
NO20006479A
Other languages
English (en)
Other versions
NO20006479D0 (no
Inventor
Shuichi Furuya
Nobuo Choh
Nobuhiro Suzuki
Takashi Imada
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO20006479D0 publication Critical patent/NO20006479D0/no
Publication of NO20006479L publication Critical patent/NO20006479L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Forbindelsen ifølge foreliggende oppfinnelse har utmerket antagonistisk virkning overfor gonadotropin-frigjørende hormon og er nyttig til forebygging eller behandling av kjønnshormon-avhengige sykdommer, f.eks. kjønnshormon-avhengige krefttyper (f.eks. prostatakreft, livmorkreft, brystkreft, hypofysetumor), prostata-hypertrofi, hysteromyom, endometriose, brå-utviklet pubertet, amenoré-syndrom, multilokulært ovariesyndrom, kviser osv., eller som graviditetsregulator (f.eks. befhiktningshindrende middel), som middel mot ufruktbarhet eller som menstruasjonsregulerende middel.
NO20006479A 1998-06-26 2000-12-19 Tienopyridinforbindelser, deres fremstilling og anvendelse NO20006479L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP18126398 1998-06-26
JP33300498 1998-11-24
PCT/JP1999/003379 WO2000000493A1 (en) 1998-06-26 1999-06-24 Thienopyridine compounds, their production and use

Publications (2)

Publication Number Publication Date
NO20006479D0 NO20006479D0 (no) 2000-12-19
NO20006479L true NO20006479L (no) 2000-12-19

Family

ID=27308836

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006479A NO20006479L (no) 1998-06-26 2000-12-19 Tienopyridinforbindelser, deres fremstilling og anvendelse

Country Status (9)

Country Link
US (1) US6262267B1 (no)
EP (1) EP1090010A1 (no)
AU (1) AU4393199A (no)
BR (1) BR9911564A (no)
CA (1) CA2331399A1 (no)
HU (1) HUP0102805A3 (no)
NO (1) NO20006479L (no)
SK (1) SK19752000A3 (no)
WO (1) WO2000000493A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4066552B2 (ja) * 1999-03-16 2008-03-26 コニカミノルタビジネステクノロジーズ株式会社 画像形成装置
US20040023987A1 (en) * 2000-06-14 2004-02-05 Yoshio Hata Sustained release compositions
EP1319409A4 (en) * 2000-09-22 2006-05-03 Takeda Pharmaceutical SOLID PREPARATIONS
WO2003064429A1 (en) 2002-01-30 2003-08-07 Takeda Chemical Industries, Ltd. Thienopyrimidines, process for preparing the same and use thereof
WO2003086464A1 (en) * 2002-04-12 2003-10-23 Takeda Pharmaceutical Company Limited. Preventives/remedies for hotflash
GB0307777D0 (en) 2003-04-04 2003-05-07 Medical Res Council Conjugate compounds
CA2536321A1 (en) 2003-08-29 2005-03-10 Pfizer Inc. Thienopyridine-phenylacet amides and their derivatives useful as new anti-angiogenic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW449600B (en) 1994-04-19 2001-08-11 Takeda Chemical Industries Ltd Condensed-ring thiophene derivatives, their production and use
CA2192283A1 (en) 1995-12-08 1997-06-09 Nobuhiro Suzuki Prolactin production inhibitory agent
AU2406597A (en) * 1996-04-26 1997-11-19 Takeda Chemical Industries Ltd. Thienopyridine derivatives, their production and use

Also Published As

Publication number Publication date
HUP0102805A3 (en) 2002-04-29
NO20006479D0 (no) 2000-12-19
CA2331399A1 (en) 2000-01-06
HUP0102805A2 (hu) 2001-11-28
BR9911564A (pt) 2001-10-09
EP1090010A1 (en) 2001-04-11
AU4393199A (en) 2000-01-17
US6262267B1 (en) 2001-07-17
SK19752000A3 (sk) 2001-08-06
WO2000000493A1 (en) 2000-01-06

Similar Documents

Publication Publication Date Title
CY1110009T1 (el) Συνθεσεις μικροδιαμερισμενης ταναπρογετης και μεθοδοι παρασκευης τους
CY1107862T1 (el) Φαρμακευτικες συνθεσεις που περιλαμβανουν παραγωγα οιστερολης για χρηση στη θεραπεια του καρκινου
NO20075849L (no) Fremgangsmater og preparater til behandling eller forebygging av kreft
PT1261367E (pt) Utilizacao de antagonistas da interleucina 6 para o tratamento de tumores dependentes de estrogenios
NO20032759D0 (no) 2-fenylbenzimidazoler og imidazo-[4,5]-pyridiner som SDSI/CHK2-inhibitorerog adjuvanter ved kjemoterapi eller strålingsterapi ved behandlingav kreft
WO2004058171A3 (en) Antibodies against gpr64 and uses thereof
CY1108462T1 (el) Χρηση της αναστροζολης για τη θεραπευτικη αντιμετωπιση μετεμμηνοπαυσιακων γυναικων με καρκινο του μαστου σε πρωιμο σταδιο
CY1110017T1 (el) Μικρονισμενη ταναπρογετη και συνθεσεις που περιεχουν αυτην
AR035450A1 (es) Combinaciones antineoplasicas, el uso de dichas combinaciones para la preparacion de un medicamento, un producto que comprende dicha combinacion
ECSP055574A (es) Uso de derivados de tio-oxindol en el tratamiento de condiciones relacionadas con hormonas.
AU2003255820A8 (en) Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
AP2004002995A0 (en) Combination therapy for the treatment of cancer
AU2002357644A8 (en) Therapeutic agents and corresponding treatments
TR200103285T2 (tr) Projesteron reseptörü modülatörleri olarak siklokarbamat türevleri.
GB9920908D0 (en) Chalcone coumarins
ES2187796T3 (es) Reactivo de peptidos que permiten la deteccion de citomegalovirus (cmv) humano.
GT200400241A (es) Prevencion y tratamiento de enfermedades cardiacas hipertensivas mediante el uso de los estrogenos selectivos8b-vinil-estra-1,3,5,(10)-trien-3,17b-diol y 17b-fluor-9a-vinil-estra-1,3,6,(10)-trien-3, 16a-diol
EA200200943A1 (ru) Гормональная терапия рака молочной железы
BR9911564A (pt) Composto, processo para produzir um composto, composição farmacêutica, processo para antagonizar o hormÈnio de liberação de gonadotropina em um mamìfero, e, uso de um composto
TW430665B (en) Thienopyridine compounds for antagonizing gonadotropin-releasing hormone and their production
IL143988A0 (en) Compositions and methods for intraductal gene therapy
DK1635843T3 (da) Terapi, der omfatter dienogest for hormonerstatning og depression
DK1345907T3 (da) 7-Heterocyclyl-quinolin- og thieno-2,3-B-pyridin-derivater anvendelige som antagonister af gonadotropin-frigörende hormon
Baeyens et al. Small cell carcinoma of the ovary successfully treated with radiotherapy only after surgery: case report
WO2003043568A3 (en) Compositions and methods for the suppression of mammary epithelial cell proliferation

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application